Evidence map›Paper›PMID 34592495›Full record

Observational studyCytokine2021

Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies.

Eula G A Neves, Carolina C Koh, José L Padilha da Silva, Lívia S A Passos, Fernanda N A Villani, Janete S C Dos Santos, Cristiane A S Menezes, Vicente R Silva, Julia P A S Tormin, Guilherme F B Evangelista and 6 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Cytokine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Valve biology and rheumatic heart disease pathogenesis.Nature cardiovascular research · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Blocking activation of CD4Clinical immunology (Orlando, Fla.) · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Eula G A NevesCell-cell Interactions Laboratory, Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Carolina C KohCell-cell Interactions Laboratory, Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
José L Padilha da SilvaStatistics Department, Federal University of Paraná, Curitiba, PR, Brazil.
Lívia S A PassosCell-cell Interactions Laboratory, Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Fernanda N A VillaniMinas Gerais State University, Divinópolis, MG, Brazil.
Janete S C Dos SantosEzequiel Dias Foundation, Belo Horizonte, MG, Brazil.
Cristiane A S MenezesDepartment of Clinical and Toxicological Analysis, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Vicente R SilvaGraduate Program in Infectology and Tropical Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Julia P A S TorminGraduate Program in Infectology and Tropical Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Guilherme F B EvangelistaHospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Andréa Teixeira de CarvalhoRene Rachou Institute, FIOCRUZ, Belo Horizonte, MG, Brazil.
Manoel Otávio da Costa RochaGraduate Program in Infectology and Tropical Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Bruno NascimentoGraduate Program in Infectology and Tropical Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Kenneth John GollobHospital Israelita Albert Einstein, São Paulo, SP, Brazil; Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais, INCT-DT, Salvador, BA, Brazil.
Maria do Carmo P NunesGraduate Program in Infectology and Tropical Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Walderez O DutraCell-cell Interactions Laboratory, Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil; Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais, INCT-DT, Salvador, BA, Brazil. Electronic address: waldutra@icb.ufmg.br.
Universidade Federal de Minas Gerais · BRHospital Israelita Albert Einstein · BREzequiel Dias Foundation · BRFundação Oswaldo Cruz · BRInstituto Nacional de Ciência e Tecnologia de Doenças Tropicais · BRUniversidade do Estado de Minas Gerais · BRUniversidade Federal do Paraná · BR

Funding

Role of CD4-CD8- DN T cells in Chagas CardiomyopathyR01AI138230 · NIAID · FOUNDATION FOR RESEARCH DEVELOPMENT · PI DUTRA, WALDEREZ O. · 2018 to 2021
$540k
NIAID NIH HHS R01 AI138230
6 · The paper itself

Abstract

Heart disease is a major cause of death worldwide. Chronic Chagas cardiomyopathy (CCC) caused by infection with Trypanosoma cruzi leading to high mortality in adults, and rheumatic heart disease (RHD), resulting from infection by Streptococcus pyogenes affecting mainly children and young adults, are amongst the deadliest heart diseases in low-middle income countries. Despite distinct etiology, the pathology associated with both diseases is a consequence of inflammation. Here we compare systemic immune profile in patients with these cardiopathies, to identify particular and common characteristics in these infectious heart diseases. We evaluated the expression of 27 soluble factors, employing single and multivariate analysis combined with machine-learning approaches. We observed that, while RHD and CCC display higher levels of circulating mediators than healthy individuals, CCC is associated with stronger immune activation as compared to RHD. Despite distinct etiologies, univariate analysis showed that expression of TNF, IL-17, IFN-gamma, IL-4, CCL4, CCL3, CXCL8, CCL11, CCL2, PDGF-BB were similar between CCC and RHD, consistent with their inflammatory nature. Network analysis revealed common inflammatory pathways between CCC and RHD, while highlighting the broader reach of the inflammatory response in CCC. The final multivariate model showed a 100% discrimination power for the combination of the cytokines IL-12p70, IL-1Ra, IL-4, and IL-7 between CCC and RHD groups. Thus, while clear immunological distinctions were identified between CCC and RHD, similarities indicate shared inflammatory pathways in these infectious heart diseases. These results contribute to understanding the pathogenesis of CCC and RHD and may impact the design of immune-based therapies for these and other inflammatory cardiopathies that may also share immunological characteristics.

Indexed as

AdultAgedChagas CardiomyopathyChemokinesCluster AnalysisCytokinesFemaleHumansIntercellular Signaling Peptides and ProteinsMaleMiddle AgedProtein Interaction MapsRheumatic Heart DiseaseSolubilityChemokinesCytokinesIntercellular Signaling Peptides and ProteinsChagas diseaseInflammationPathologyRheumatic heart diseaseSystemic immune profile

Identifiers

PMID34592495
PMCPMC8546740
OpenAlexW3202354881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.